| Title |
New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness
|
|---|---|
| Published in |
Drug Design, Development and Therapy, June 2014
|
| DOI | 10.2147/dddt.s45644 |
| Pubmed ID | |
| Authors |
Helen Mani, Edelgard Lindhoff-Last |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 137 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| Denmark | 1 | <1% |
| Slovenia | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 133 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 25 | 18% |
| Student > Bachelor | 19 | 14% |
| Researcher | 18 | 13% |
| Student > Doctoral Student | 16 | 12% |
| Other | 12 | 9% |
| Other | 27 | 20% |
| Unknown | 20 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 62 | 45% |
| Pharmacology, Toxicology and Pharmaceutical Science | 19 | 14% |
| Economics, Econometrics and Finance | 7 | 5% |
| Agricultural and Biological Sciences | 5 | 4% |
| Nursing and Health Professions | 5 | 4% |
| Other | 13 | 9% |
| Unknown | 26 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 September 2015.
All research outputs
#8,127,820
of 25,806,080 outputs
Outputs from Drug Design, Development and Therapy
#556
of 2,283 outputs
Outputs of similar age
#72,459
of 241,821 outputs
Outputs of similar age from Drug Design, Development and Therapy
#13
of 49 outputs
Altmetric has tracked 25,806,080 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 2,283 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 241,821 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.